Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04201340 · ClinicalTrials.gov registry record
Topcon DRI OCT Triton With SS-OCT Angio Software Evaluation Study
A clinical trial, sponsored by Topcon Corporation.
- Completed
- Registry status
- 211
- Enrollment target
NCT04201340: Completed study, sponsored by Topcon Corporation.
NCT04201340 is a clinical trial that has completed, run by Topcon Corporation. The registered enrollment target is 211 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04201340 has completed, sponsored by Topcon Corporation.
- COMPLETED
- Registry status
- 211 participants
- Enrollment target
Study Summary
Comparisons for vascular structure visualization in the retina and choroid.
Primary Outcome
Comparison of OCT devices to TRC-50DX
Interventions
- DEVICE Cirrus HD-OCT 5000
- DEVICE TRC-50DX
- DEVICE DRI OCT Triton with SS-OCT Angio software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2019-12-11 |
| Est. Completion | 2022-10-20 |
What the finished NCT04201340 record still lists
NCT04201340 is an observational study that tracks outcomes without assigning an intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Cirrus HD-OCT 5000 is the first listed.
NCT04201340 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04201340 about?
NCT04201340 is a clinical study titled "Topcon DRI OCT Triton With SS-OCT Angio Software Evaluation Study". Comparisons for vascular structure visualization in the retina and choroid.
What is the current status of trial NCT04201340?
This trial is currently completed. The enrollment target is 211 participants. The study started on 2019-12-11. Estimated completion is 2022-10-20.
What interventions are being tested in trial NCT04201340?
The interventions under investigation include: Cirrus HD-OCT 5000 (DEVICE), TRC-50DX (DEVICE), DRI OCT Triton with SS-OCT Angio software (DEVICE).
Who is sponsoring clinical trial NCT04201340?
This trial is sponsored by Topcon Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI